Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
1) Feds join second Medicare Advantage fraud lawsuit against UnitedHealth. Modern Healthcare, March 28, 2017.
The DOJ has joined another lawsuit against UnitedHealth Group alleging that the insurer claimed patients were sicker than they were.
2) Company, officers charged in scheme to sell misbranded prescription drugs. Pittsburgh Post-Gazette, March 28, 2017.
A Canadian drug company and its top officers have been charged with conspiring to distribute misbranded prescription drugs in the U.S.
3) FDA declines to approve Mylan’s generic of GSK’s Advair for now. Reuters, March 29, 2017.
The FDA did not approve Mylan’s generic copy of Advair, a two-part drug used to treat asthma and chronic lung disease.
4) Celgene is scolded by the Japanese government for failing to report side effects. STAT, March 29, 2017.
Japan issued a business improvement order to Celgene for failing to report over 4,500 side effect cases for three of its drugs.
5) Senate tax chief sees room for repealing Obamacare levies in tax reform drive. Reuters, March 30, 2017.
A push to change the tax code could include the repeal of Obamacare taxes.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. CLICK HERE TO SUBSCRIBE.
P.S. If you or your patients are interested in consumer healthcare issues, check out myhealthspin.com.
